Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Premier ( (PINC) ) has shared an update.
On September 21, 2025, Premier, Inc. announced a merger agreement to be acquired by Patient Square Capital, with stockholders receiving $28.25 per share in cash. The transaction, valued at $2.6 billion, is expected to close by the first quarter of 2026, subject to regulatory and stockholder approvals. The merger aims to enhance Premier’s financial flexibility and provide additional resources for innovation, with the company’s stock to be delisted from NASDAQ upon completion.
The most recent analyst rating on (PINC) stock is a Sell with a $21.00 price target. To see the full list of analyst forecasts on Premier stock, see the PINC Stock Forecast page.
Spark’s Take on PINC Stock
According to Spark, TipRanks’ AI Analyst, PINC is a Neutral.
Premier’s overall stock score reflects a mix of strengths and challenges. The most significant factor is the strong earnings call performance and positive future guidance, which is offset by technical indicators suggesting overbought conditions and a high valuation. Financial stability is a positive, but declining revenue and profitability margins present risks.
To see Spark’s full report on PINC stock, click here.
More about Premier
Premier, Inc. is a leading technology-driven healthcare improvement company based in Charlotte, N.C. It plays a critical role in the healthcare industry by uniting providers, suppliers, payers, and policymakers to enhance healthcare through integrated data and analytics, supply chain solutions, consulting, and other services.
Average Trading Volume: 1,904,111
Technical Sentiment Signal: Buy
Current Market Cap: $2.13B
See more data about PINC stock on TipRanks’ Stock Analysis page.